Sequent Medical Awarded U.S. Patent For Microbraid Technology
ALISO VIEJO, Calif. – September 18, 2012 – Sequent Medical, Inc. announced
today the award by the U.S. Patent and Trademark Office of Patent No.
8,261,648, entitled "Braiding Mechanism and Method of Use."
The company has developed proprietary MicroBraid™ technology to create the
WEB® Aneurysm Embolization System. MicroBraid technology allows the
fabrication of fine wire braided devices, such as the WEB, that optimize key
properties of porosity, radial compliance, and collapsed profile.
Building on the experience with endovascular embolic coils, the WEB enables
physicians to treat intracranial aneurysms with the familiarity of an
intra-saccular approach using established biomaterials. The WEB is designed
to bridge the aneurysm neck and to promote rapid peri-procedural stasis in
both ruptured and un-ruptured aneurysms. The initial WEB configurations
offer a treatment alternative for wide-necked bifurcation aneurysms, which
are among the more difficult aneurysms to treat using other endovascular
"We are pleased to have achieved this important milestone in our ongoing
efforts to develop our intellectual property portfolio," said Tom Wilder,
President & CEO of Sequent Medical. "The utility of this patented braiding
technology extends beyond the neurovascular field, and has the potential to
address a number of unmet clinical needs."
About Sequent Medical, Inc.
Sequent Medical, Inc. (www.sequentmedical.com
) is a privately held medical-device company that is
dedicated to the development of innovative catheter-based neurovascular
technologies. The WEB Aneurysm Embolization System has received the CE mark,
and is approved for use in several regions in addition to Europe. It is not
available for either investigational or commercial use in the United States.
Sequent Medical, Inc. is headquartered in Aliso Viejo, California, and has
European operations based in Bonn, Germany. Sequent licensed its MicroBraid
technology to Inceptus Medical LLC for use in
select cardiovascular medical device applications.